These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1094993)

  • 1. Acquired toxoplasmosis. A neglected cause of treatable nervous system disease.
    Townsend JJ; Wolinsky JS; Baringer JR; Johnson PC
    Arch Neurol; 1975 May; 32(5):335-43. PubMed ID: 1094993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasmosis in the compromised host.
    Ruskin J; Remington JS
    Ann Intern Med; 1976 Feb; 84(2):193-9. PubMed ID: 766683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Encephalic pseudotumoral toxoplasmosis in the course of blood diseases].
    Masson R; Fière D; Lahnèche B; Cordat C; Berger F; Revol L
    Nouv Presse Med; 1975 Oct; 4(35):2499-502. PubMed ID: 1060053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmosis. Problems in diagnosis and treatment.
    Hakes TB; Armstrong D
    Cancer; 1983 Oct; 52(8):1535-40. PubMed ID: 6616413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic and developmental outcome in treated congenital toxoplasmosis.
    Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
    Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable outcome of central nervous system toxoplasmosis occurring in a patient with untreated Hodgkin's disease.
    Green JA; Spruance SL; Cheson BD
    Cancer; 1980 Feb; 45(4):808-10. PubMed ID: 7357497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of pneumocystosis and toxoplasmosis in the immunosuppressed host.
    Remington JS; Anderson SE
    Transplant Proc; 1973 Sep; 5(3):1263-70. PubMed ID: 4580723
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.
    Wanke C; Tuazon CU; Kovacs A; Dina T; Davis DO; Barton N; Katz D; Lunde M; Levy C; Conley FK
    Am J Trop Med Hyg; 1987 May; 36(3):509-16. PubMed ID: 3495190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
    Leport C; Raffi F; Matheron S; Katlama C; Regnier B; Saimot AG; Marche C; Vedrenne C; Vilde JL
    Am J Med; 1988 Jan; 84(1):94-100. PubMed ID: 3337134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.
    Roemer E; Blau IW; Basara N; Kiehl MG; Bischoff M; Günzelmann S; Kirsten D; Sanchez H; Wocker EL; Fauser AA
    Clin Infect Dis; 2001 Jan; 32(1):E1-8. PubMed ID: 11118397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachycardia in a patient with toxoplasmosis.
    Mary AS; Hamilton M
    Br Heart J; 1973 Mar; 35(3):349-52. PubMed ID: 4692665
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxoplasmosis in kidney transplant recipients: a life-threatening but treatable disease.
    Renoult E; Georges E; Biava MF; Hulin C; Frimat L; Hestin D; Kessler M
    Transplant Proc; 1997; 29(1-2):821-2. PubMed ID: 9123542
    [No Abstract]   [Full Text] [Related]  

  • 13. Serologic evidence for acute toxoplasmosis in polymyositis-dermatomyositis. Increased frequency of specific anti-toxoplasma IgM antibodies.
    Magid SK; Kagen LJ
    Am J Med; 1983 Aug; 75(2):313-20. PubMed ID: 6349349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of clindamycin in the treatment of central nervous system toxoplasmosis.
    Rolston KV; Hoy J
    Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of toxoplasmosis by renal transplant: a report of four cases.
    Renoult E; Biava MF; Hulin C; Frimat L; Hestin D; Kessler M
    Transplant Proc; 1996 Feb; 28(1):181-3. PubMed ID: 8644168
    [No Abstract]   [Full Text] [Related]  

  • 16. Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.
    Pedrol E; González-Clemente JM; Gatell JM; Mallolas J; Miró JM; Graus F; Alvarez R; Mercader JM; Berenguer J; Jiménez de Anta MT
    AIDS; 1990 Jun; 4(6):511-7. PubMed ID: 2386616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between toxoplasmosis and pityriasis lichenoides chronica.
    Nassef NE; Hammam MA
    J Egypt Soc Parasitol; 1997 Apr; 27(1):93-9. PubMed ID: 9097531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Streptococcus angina, myocarditis and toxoplasmosis following splenectomy].
    Renschler HE; Schumacher K
    Internist (Berl); 1970 Apr; 11(4):150-1. PubMed ID: 4933147
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pericardial manifestations of toxoplasmosis].
    Guérot E; Assayag P; Morgant C; Hess M; Valère PE
    Arch Mal Coeur Vaiss; 1992 Jan; 85(1):109-11. PubMed ID: 1550430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii encephalitis in systemic lupus erythematosus. A neglected cause of treatable nervous system infection.
    Deleze M; Mintz G; del Carmen Mejia M
    J Rheumatol; 1985 Oct; 12(5):994-6. PubMed ID: 4087277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.